How should cellulitis of the lower limb be managed in a patient with a total leukocyte count of 1400 cells/µL and neutrophils 74%?

Management of Lower Limb Cellulitis with Severe Neutropenia

This patient requires immediate hospitalization with broad-spectrum intravenous antibiotics (vancomycin plus piperacillin-tazobactam or a carbapenem) due to severe immunocompromise from neutropenia (TLC 1400/µL), which classifies them as a severely compromised host requiring aggressive empiric coverage. 1

Risk Stratification

This patient falls into the "severely compromised" category based on:

• Absolute neutrophil count: With 74% neutrophils of 1400 TLC = ~1036 cells/µL (severe neutropenia, <1500/µL)
• Severe cell-mediated immunodeficiency requiring blood cultures and tissue sampling 1

The IDSA guidelines explicitly state that severely compromised patients (including those with neutropenia) warrant broad-spectrum antimicrobial coverage 1.

Immediate Management Algorithm

1. Hospitalization is Mandatory

• Infection in a severely immunocompromised patient is an absolute indication for admission 1
• Outpatient therapy is contraindicated regardless of hemodynamic stability

2. Diagnostic Workup

• Blood cultures (mandatory in neutropenic patients) 1
• Cutaneous aspirates, biopsies, or swabs should be obtained 1
• Baseline inflammatory markers
• Imaging if concern for deeper infection or necrotizing process

3. Empiric Antibiotic Regimen

Vancomycin PLUS piperacillin-tazobactam is the recommended combination 1:

• Vancomycin 15 mg/kg IV every 12 hours
• Piperacillin-tazobactam 4.5 g IV every 8 hours

Alternative: Vancomycin plus imipenem/meropenem 1

This broad coverage addresses:

• MRSA and streptococci (primary cellulitis pathogens)
• Gram-negative organisms (risk in neutropenic patients)
• Polymicrobial infections

4. Febrile Neutropenia Considerations

Since this patient has neutropenia with infection, apply febrile neutropenia principles 2:

• If fever develops or persists at 48 hours despite clinical stability, continue initial antibacterial therapy
• If clinically unstable, rotate antibacterials or broaden coverage
• Consider antifungal therapy if fever persists >4-6 days 2
• Seek infectious disease consultation immediately

Duration and Monitoring

• Minimum 5 days of IV antibiotics, but extend if no improvement 1
• In neutropenic patients, antibiotics are often continued until:
  • Neutrophil count recovers to ≥0.5 × 10⁹/L
  • Patient afebrile for 48 hours (if neutrophils recovered) 2
  • Or up to 10 days in high-risk cases 2

Critical Pitfalls to Avoid

1. Do NOT use oral antibiotics - this patient requires IV therapy
2. Do NOT use standard cellulitis regimens (penicillin/cephalexin alone) - inadequate for immunocompromised hosts
3. Do NOT delay hospitalization - neutropenia with active infection is high-risk for rapid deterioration
4. Do NOT forget to examine interdigital toe spaces for fungal infection/fissuring as entry portal 1

Adjunctive Measures

• Limb elevation 1
• Treat predisposing factors (edema, toe web abnormalities) 1
• Avoid corticosteroids - contraindicated in immunocompromised patients despite potential benefit in immunocompetent hosts 1

Follow-up Decision Points

At 48 hours:

• If clinically stable: continue same regimen
• If deteriorating: seek expert ID consultation and consider imaging for abscess/necrotizing infection 2

At 4-6 days:

• If persistent fever with rising inflammatory markers: initiate antifungal therapy and image chest/abdomen 2